ClinicalTrials.Veeva

Menu

Electrochemotherapy for the Inoperable Vulva Carcinoma

U

University Hospital Tuebingen

Status

Completed

Conditions

Advanced Inoperable Vulva Carcinoma

Treatments

Procedure: Electrochemotherapy

Study type

Interventional

Funder types

Other

Identifiers

NCT03142061
558/2015BO1

Details and patient eligibility

About

Electrochemotherapy (ECT) with Bleomycin in non-operable advanced vulva carcinoma

Full description

Prospective evaluation of tumor response towards ECT by photo documentation. In addition prospective documentation of life quality after ECT treatment as well as evaluation of pain. .

Enrollment

50 patients

Sex

Female

Ages

55+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • informed consent
  • age ≥ 55 years (postmenopausal)
  • histologically proved cutan accessible vulva carcinoma
  • a maximum of 5 lesions ≥1 - ≤ 5 cm diameter; a maximum thickness of 3 cm
  • applied electrochemotherapy with electroporation

Exclusion criteria

  • Non compliant patients
  • Patients with symptomatic or rapidly progredient metastasis outside of the vulva

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

ECT
Experimental group
Treatment:
Procedure: Electrochemotherapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems